Genotypic resistance to antiretroviral drugs in patients with therapeutic failure to highly active antiretroviral therapy (Q43948814)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Genotypic resistance to antiretroviral drugs in patients with therapeutic failure to highly active antiretroviral therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

main subject

anti-retroviral agent

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

F Gutiérrez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C Escolano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Mora

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

F Pasquau

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Gregori

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

E Nogueira

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 October 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

401-404

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093841%20AND%20SRC:MED&resulttype=core&format=json

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971574-0

Resistance, fitness, adherence, and potency: mapping the paths to virologic failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971574-0

Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971574-0

Long-read direct infrared sequencing of crude PCR products for prediction of resistance to HIV-1 reverse transcriptase and protease inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971574-0

Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971574-0

Introduction of HIV drug-resistance testing in clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971574-0

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971574-0

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971574-0

Chemokines and receptors in HIV encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971574-0

Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971574-0

Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971574-0

Impact of drug resistance mutations on virologic response to salvage therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971574-0

Resistance Profiles in Patients with Viral Rebound on Potent Antiretroviral Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971574-0

HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971574-0

10.1016/S0025-7753(00)71574-0

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093841%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11093841%20AND%20SRC:MED&resulttype=core&format=json